Howard Bernstein

2022

In 2022, Howard Bernstein earned a total compensation of $1.6M as Interim Chief Executive Officer at SQZ Biotechnologies Co, a 21% increase compared to previous year.

Compensation breakdown

Option Awards$1,072,376
Salary$400,227
Other$151,910
Total$1,624,513

Bernstein received $1.1M in option awards, accounting for 66% of the total pay in 2022.

Bernstein also received $400.2K in salary and $151.9K in other compensation.

Rankings

In 2022, Howard Bernstein's compensation ranked 2,094th out of 5,736 executives tracked by ExecPay. In other words, Bernstein earned more than 63.5% of executives.

ClassificationRankingPercentile
All
2,094
out of 5,736
64th
Division
Manufacturing
1,126
out of 3,125
64th
Major group
Chemicals And Allied Products
484
out of 1,416
66th
Industry group
Drugs
444
out of 1,317
66th
Industry
Biological Products, Except Diagnostic Substances
109
out of 291
63rd
Source: SEC filing on April 26, 2023.

Bernstein's colleagues

We found four more compensation records of executives who worked with Howard Bernstein at SQZ Biotechnologies Co in 2022.

2022

Armon Sharei

SQZ Biotechnologies Co

Chief Executive Officer

2022

Micah Zajic

SQZ Biotechnologies Co

Chief Financial Officer

2022

Lawrence Knopf

SQZ Biotechnologies Co

General Counsel

2022

Marshelle Warren

SQZ Biotechnologies Co

Chief Medical Officer

News

In-depth

You may also like